← Insider buys
EDIT

Editas Medicine, Inc. · Healthcare

Chief Scientific Officer Charles Albright sold $147K of Editas Medicine, Inc.

Sold$147,288
$26.54Price
5,549Shares
−21%Stake

What EDIT did after the filing

Prices for EDIT after this filing aren't in yet.

Traded Mon, Feb 3. Filed Tue, Feb 4, 12:24 PM ET, during the session. Not investment advice.